##semicolon##
Аллогенная трансплантация, вирусный гепатит, гемопоэтические стволовые клетки.##submission.citations##
Adinolfi LE, et al. Hepatitis C virus–associated cardiovascular disorders. Seminars in Liver Disease. 2014 Nov;34(2):133–144.
Cacoub P, et al. Extrahepatic manifestations of chronic hepatitis C virus infection. Digestive and Liver Disease. 2014 Nov;46(11):S165–73.
Loomba R, Liang TJ. Hepatitis B reactivation associated with immune suppressive and biological modifier therapies: current concepts, management strategies, and future directions. Gastroenterology. 2017 May;152(6):1297–1309.
Perrillo RP. Hepatitis B reactivation from cytotoxic chemotherapy: recognition and management. Hematology Am Soc Hematol Educ Program. 2001;2001(1):22–36.
World Health Organization. Global Hepatitis Report, 2017. Geneva: WHO; 2017.
Sanyal AJ, Yoon SK, Lencioni R. The etiology of hepatocellular carcinoma and consequences for treatment. The Oncologist. 2010 Apr;15(S4):14–22.
Kim WR. Epidemiology of hepatitis B in the United States. Hepatology. 2009 May;49(S5):S28–34.
Younossi ZM, et al. Extrahepatic manifestations of chronic hepatitis C. Journal of Hepatology. 2007 Oct;46(5):620–631.
Wu CY, et al. Hepatitis B virus infection and the risk of stroke: a nationwide population–based study. Journal of Hepatology. 2011 Dec;54(4):894–899.
Lee JH, et al. Chronic hepatitis B and risk of ischemic stroke: a cohort study in South Korea.Stroke.2010 Sep;41(9):2137–2142.
European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. Journal of Hepatology. 2017 Aug;67(2):370–398.
Petta S, et al. Hepatitis C virus infection is associated with increased cardiovascular mortality: a meta–analysis of observational studies. Gastroenterology. 2016 Aug;150(1):145–155.e4.
Negro F. Mechanisms of hepatitis C virus–related insulin resistance. Clinical Liver Disease. 2009 Nov;13(4):445–455.
Knobler H, Schattner A. TNF–α, chronic hepatitis C and diabetes: a novel triad. QJM: An International Journal of Medicine. 2005 Apr;98(1):1–6.
Mehta SH, et al. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Annals of Internal Medicine. 2000 Aug;133(8):592–599.
Chen YC, et al. Chronic hepatitis B virus infection and immune dysfunction. Trends in Microbiology. 2016 Oct;24(10):666–679.
Pozzato G, et al. Hepatitis C virus and non–Hodgkin's lymphoma. Clinical Liver Disease. 2015 Feb;19(1):107–120.
Duberg AS, et al. Hepatitis C infection and the risk of malignant lymphoma: a population–based cohort study in Sweden. Journal of the National Cancer Institute. 2005 Oct;97(18):1330–1335